Transitional Care Program for Fluid Overload in Cirrhosis

Last updated: February 18, 2025
Sponsor: Milton S. Hershey Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hepatic Fibrosis

Hyponatremia

Scar Tissue

Treatment

Transitional Care Program

Clinical Study ID

NCT06174272
STUDY00023071
  • Ages > 18
  • All Genders

Study Summary

The goal of this clinical trial is to learn about an intensive monitoring plan (transitional care program) in patients with cirrhosis and excessive swelling that are going to be discharged from the hospital.

The main question[s] it aims to answer are:

  • How much time and what resources are needed to run such a program

  • How well do patients follow up with the phone calls, bloodwork, and doctor appointments?

  • Do the patients enrolled in the program have less need for hospitalization later, less kidney injury, better fluid control, and/or better survival compared to patients that are not in the program?

Participants will

  • Be given a digital scale and a binder with educational material and a log to monitor their weights after discharge from the hospital

  • Receive a phone call from the study team within 72 hours of discharge and weekly

  • Be given a follow up appointment with hepatology within 4 weeks of discharge

Researchers will compare participants in this program to patients that receive normal care to see if there are differences in need for hospitalization later, kidney injury, fluid control, and/or survival.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients > 18 years of age.

  • Inpatient at Penn State Health, Milton S. Hershey Medical Center.

  • Diagnosis of cirrhosis.

  • Hospitalized with fluid overload (ascites and/or significant anasarca/edema)requiring diuretic therapy.

  • English speaking

Exclusion

Exclusion Criteria:

  • Placement of a TIPS.

  • Ascites from an etiology other than cirrhosis, such as malignancy, heart failure,pancreatitis, nephrotic syndrome.

  • Non-English speaking

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Transitional Care Program
Phase:
Study Start date:
February 15, 2025
Estimated Completion Date:
June 01, 2026

Connect with a study center

  • Penn State Milton S. Hershey Medical Center

    Hershey, Pennsylvania 17033
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.